https://icardio.aiiCardio.ai is a Los Angeles-based deep learning startup automating the interpretation of heart ultrasounds. iCardio.ai’s core AI products are trained on over +200 million images. iCardio.ai has teamed with some of the largest Ultrasound vendors, including Abbott, Butterfly Network, and UltraLinQ, to deliver its technology to clinicians around the globe. In February of 2024, iCardio.ai received Breakthrough Designation by the FDA for its automated capability to detect Aortic Stenosis from b-mode ultrasound imagery. In October of 2024, iCardio.ai received 510(k) FDA Clearance for its AI system for automated echocardiography.

https://datenight.aiFounded by Ian Mark, DateNight.ai offers virtual speed dating software for communities around the world. DateNight.ai was spun out of CoronaCrush, a Jewish dating group with over 20,000 participants.

https://olehpay.co.ilOlehPay, LLC, a privately held, multinational financial technology company operating an online remittance platform, serves as a digital alternative for traditional money transfer and currency exchange. The OlehPay platform primarily serves the American expat community within Israel with a large focus on the automation of remitting pension payments, social security deposits, American-based salaries, and Israeli-based mortgage payments. OlehPay also provides services for funding down payments for property purchases in Israel.

https://airplant.gardenAirplantGardens sells a monthly direct-to-consumer plant subscription box. Customers receive an assorted airplant each month. The company spun out in the lul of covid and quickly gained traction through micro-influencer marketing. The company went from ideation to exit in just 11 months, eventually selling to private equity in the summer of the year after.

https://mellitushealth.comInsulin Algorithms, now MellitusHealth (https://mellitushealth.com/), serves a precise insulin dosing recommendations system through its DeNovo FDA-cleared Class II proprietary algorithm. The firms technology allows clinicians across the healthcare continuum to make recommendations on insulin dosing. The technology has been shown to reduce hba1c for patients and reduce downstream costs to healthcare institutions. In my time at Insulin Algorithms, I leveraged my own expertise as a Type 1, contributing to the development and validation of the v1 product.